#5 Up and to the right: How Limbic is tackling the supply-demand problem of mental health care

Hi friends,

If you’re new here, welcome!

I'm Steve Duke and this is where I write about what is happening in mental health innovation.

My goal? To give founders and operators actionable insights they can use to maximise their impact in mental health.A few weeks ago I wrote about Limbic, the UK based company developing mental health AI tech. They had just raised $14m in a round led by Khosla Ventures and the more I read about them, the more I was intrigued. 

Their product had been adopted by 40% of NHS Talk Therapy providers with over 280,000 patients using it. They’d also published a bunch of impressive research supporting positive clinical outcomes. 

I wanted to learn more. 

What was the story behind this company, what were they getting right and what were they planning for the future?

So I caught up with Ross Harper, CEO and Co-Founder of Limbic for a chat. 

In today’s post, we go deep on Limbic, sharing insights from Ross on what makes Limbic special and how they think about addressing our mental health crisis.This week in The Hemingway Report:

• Limbic: their approach to tackling the supply-demand problem of mental health care and what we can learn from them

• Maternal Mental Health: the startup that just raised $12.6m to expand virtual mental health services to women on their parenthood journey.

• Our Mental Health Funding Database: in case you missed it… we made a database of all mental health investors and grants which you can access for free.

• Flow Neuroscience: The company developing at-home brain stimulation headsets to reduce symptoms of depression.

This article is for THR Pro members only